Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
0.390
+0.001 (0.36%)
At close: Nov 20, 2024, 4:00 PM
0.385
-0.005 (-1.26%)
Pre-market: Nov 21, 2024, 7:02 AM EST
Aethlon Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
5.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 574.25K | 280.08K | 95.21% |
| Mar 31, 2022 | 294.17K | -364.94K | -55.37% |
| Mar 31, 2021 | 659.10K | 8.92K | 1.37% |
| Mar 31, 2020 | 650.19K | 420.56K | 183.15% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SunLink Health Systems | 31.81M |
| Biomerica | 5.51M |
| Kindly MD | 2.88M |
| Mainz Biomed | 917.20K |
| Biora Therapeutics | 892.00K |
| Mangoceuticals | 755.00K |
| Organovo Holdings | 103.00K |
AEMD News
- 7 days ago - Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally - Newsfile Corp
- 7 days ago - Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update - PRNewsWire
- 9 days ago - Innovative Medical Technology Advances with First Patient Enrollments - Newsfile Corp
- 10 days ago - Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia - PRNewsWire
- 15 days ago - Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024 - PRNewsWire
- 6 weeks ago - Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit - PRNewsWire
- 2 months ago - Immunotherapy Clinical Trials - A New Approach to Treating Cancer - Newsfile Corp